Get started
Author

Tomas Koltai

Observed names: Koltai T., Koltai, Tomas, T. Koltai
ORCID: 0000-0002-7398-5096
Observed ORCID: 0000-0002-7398-5096
OpenAlex ID: A5024538800
Clusterin: a key player in cancer chemoresistance and its inhibition
2014 · Tomas Koltai · OncoTargets and Therapy · 152
PDF
Cancer: fundamentals behind pH targeting and the double-edged approach
2016 · Tomas Koltai · OncoTargets and Therapy · 106
PDF
Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review
2022 · Tomas Koltai, Stephan Joel Reshkin, et al. · Cancers · 105
PDF
Nelfinavir and other protease inhibitors in cancer: mechanisms involved in anticancer activity
2015 · Tomas Koltai · F1000Research · 74
PDF
Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physicochemical Barriers and Metabolism as Therapeutic Approaches
2021 · Tiago M. A. Carvalho, Daria Di Molfetta, et al. · Cancers · 68
PDF
Voltage-gated sodium channel as a target for metastatic risk reduction with re-purposed drugs
2015 · Tomas Koltai · F1000Research · 51
PDF
The Ph paradigm in cancer
2020 · Tomas Koltai · European Journal of Clinical Nutrition · 40
Nelfinavir and other protease inhibitors in cancer: mechanisms involved in anticancer activity
2015 · Tomas Koltai · F1000Research · 35
The complex relationship between multiple drug resistance and the tumor pH gradient: a review
2022 · Tomas Koltai · Cancer Drug Resistance · 32
PDF
Dichloroacetate for Cancer Treatment: Some Facts and Many Doubts
2024 · Tomas Koltai, Larry Fliegel · Pharmaceuticals · 27
Exploring monocarboxylate transporter inhibition for cancer treatment
2024 · Tomas Koltai, Larry Fliegel · Exploration of Targeted Anti-tumor Therapy · 24
Targeting the pH Paradigm at the Bedside: A Practical Approach
2020 · Tomas Koltai · International Journal of Molecular Sciences · 24
PDF
Fenofibrate in cancer: mechanisms involved in anticancer activity
2015 · Tomas Koltai · F1000Research · 24
The Relationship between Trop-2, Chemotherapeutic Drugs, and Chemoresistance
2023 · Tomas Koltai, Larry Fliegel · International Journal of Molecular Sciences · 22
Earlier Diagnosis of Pancreatic Cancer: Is It Possible?
2023 · Tomas Koltai · Cancers · 22
PDF
Triple-edged therapy targeting intracellular alkalosis and extracellular acidosis in cancer
2017 · Tomas Koltai · Seminars in Cancer Biology · 22
Synergy Between Low Dose Metronomic Chemotherapy and the pH-Centered Approach Against Cancer
2019 · Tomas Koltai, Rosa A. Cardone, et al. · International Journal of Molecular Sciences · 20
PDF
Targeting the Stromal Pro-Tumoral Hyaluronan-CD44 Pathway in Pancreatic Cancer
2021 · Tomas Koltai, Stephan Joel Reshkin, et al. · International Journal of Molecular Sciences · 15
PDF
Curing cancer? Further along the new pH-centric road and paradigm
2018 · S. Harguindey, T. Koltai, et al. · Oncoscience · 14
PDF
Genetic Signature of Human Pancreatic Cancer and Personalized Targeting
2024 · Stephan J. Reshkin, Rosa Angela Cardone, et al. · Cells · 13
PDF
Tumor Microenvironment Modulates Invadopodia Activity of Non-Selected and Acid-Selected Pancreatic Cancer Cells and Its Sensitivity to Gemcitabine and C18-Gemcitabine
2024 · Tiago M. A. Carvalho, Madelaine Magalì Audero, et al. · Cells · 9
PDF
Anoikis: To Die or Not to Die?
2026 · Tomas Koltai, Larry Fliegel · International Journal of Molecular Sciences · 6
PDF
Role of pH in Regulating Cancer Pyrimidine Synthesis
2022 · Saad Saeed Alqahtani, Tomas Koltai, et al. · Journal of Xenobiotics · 5
PDF
Iron metabolism in prostate cancer
2021 · Tomas Koltai, Stephan J. Reshkin, et al. · Elsevier eBooks · 5
Pharmacological interventions part III
2020 · Tomas Koltai, Stephan J. Reshkin, et al. · Elsevier eBooks · 4
Works count: 140
Citation count: 962
H-index: 17
I10-index: 20
Year
Topic
Type